T2 Biosystems (TTOO) Stock Statistics & Valuation Metrics

T2 Biosystems has a market cap or net worth of $3.08M. The enterprise value is $52.11M.

T2 Biosystems has 28,045,418 shares outstanding. The number of shares has decreased by -2.65% in one year.

T2 Biosystems’s return on equity (ROE) is 1.79 and return on invested capital (ROIC) is -230.51%.

The current PE Ratio of T2 Biosystems is -0.33. T2 Biosystems’s PEG ratio is <0.01.

In the last 12 months, T2 Biosystems had revenue of 7.19M and earned -50.08M in profits. Earnings per share was -19.19.

In the last 12 months, operating cash flow was -36.59M and capital expenditures -26.00K, giving a free cash flow of -36.62M billion.

T2 Biosystems pays an annual dividend of ―, resulting in a dividend yield of ―

T2 Biosystems upcoming earnings date is May 13, 2025, TBA Not Confirmed.

T2 Biosystems as a current ratio of 0.45, with Debt / Equity ratio of -161.78%

In the past 12 months, T2 Biosystems has paid 0.00 in taxes.

T2 Biosystems EV to EBITDA ratio is -1.14, with an EV/FCF ratio of -1.04.

T2 Biosystems has $2.08M in cash and marketable securities with $0.00 in debt, giving a net cash position of $16.86M billion.

Gross margin is -77.73%, with operating margin of -690.45%, and net profit margin of -696.19%.

The average price target for T2 Biosystems is ―, which is 11.43% higher than the current price. The consensus rating is ―